Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales
May 25, 2018 at 00:24 AM EDT
MELBOURNE, May 25 (Reuters) - An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor.
